GlaxoSmithkline Consumer Healthcare (Delisted) financials and balance sheet

BSE: 500676

Formerly Smithkline Beecham Consumer Healthcare

Last traded ₹10,732.60 on 15 Apr 2020

Delisted on 24 Jun 2021.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to December, then March.GlaxoSmithkline Consumer Healthcare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹4,782 Cr, year to Mar 2019

Operating and net margin, per cent

  • Operating margin
  • Net margin

The company moved its year end from December to March: its last year to December on record ended in Dec 2012, its first year to March in Mar 2015.

Results for the year to Mar 2019

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue4,782
  2. Materials and goods−1,436
  3. Employee costs−645
  4. Other expenses−1,560
  5. Operating profit1,141
  6. Depreciation−61
  7. Other income+433
  8. One-off items0.0
  9. Finance costs−0.8
  10. Profit before tax1,512
  11. Tax−529
  12. Net profit983

What the company owns

  • Cash and bank₹4,097 Cr
  • Plant, investments and other assets₹1,120 Cr
  • Inventory₹465 Cr
  • Receivables₹386 Cr

What pays for it: net worth and liabilities

  • Net worth₹4,095 Cr
  • Other liabilities₹1,021 Cr
  • Owed to suppliers₹953 Cr

Profit and loss

Standalone, ₹ crore, years to December, then March. No results on record for the year to Mar 2014.GlaxoSmithkline Consumer Healthcare quarterly results

₹ croreDec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 10 May
Revenue from operations1,9842,3742,7713,188–4,3084,3094,4214,3774,782
–––2,612–3,5773,4733,5883,4943,641
Materials and goods bought5416727911,152–1,4991,3441,2971,4331,436
Employee costs–––––––––645
Other expenses–––––––––1,560
Operating profit before depreciation–––576–7318368338831,141
Operating margin–––18.1%–17.0%19.4%18.9%20.2%23.9%
Materials, % of revenue–––––––––30.0%
Employee costs, % of revenue–––––––––13.5%
Other expenses, % of revenue–––––––––32.6%
Depreciation and amortisation–––36–6257646461
Operating profit after depreciation–––540–6697787698191,080
Other income275080114–222279244257433
Finance costs4332–11321
One-off items–––––––––0
Profit before tax354452540649–8891,0551,0101,0741,512
121152185212–306368354374529
Net profit233300355437–584687657700983
Other comprehensive income–––––––––7
Total comprehensive income–––––––––990
Net margin11.7%12.6%12.8%13.7%–13.5%15.9%14.9%16.0%20.6%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Dec 2012, Mar 2015, Mar 2016, Mar 2017 and Mar 2018 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Dec 2009, Dec 2010 and Dec 2011: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 December, then 31 March.

₹ croreMar 2019Filed 10 May
4,095
Share capital42
Reserves4,053
Borrowings0
1,814
159
Total assets6,068
801
5,267
Net debt−4,097
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Dec 2009, Dec 2010, Dec 2011, Dec 2012, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Per share

Standalone, ₹ per share, years to December, then March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 10 May
Earnings per share₹156.15₹166.47₹233.69
Diluted earnings per share₹156.15₹166.47₹233.69
Book value per share––₹973.54
Market cap at the year end (₹ crore)––30,480

Ratios

Standalone, years to December, then March.

RatioDec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 10 May
Revenue growth24.6%19.6%16.7%15.0%––0.0%2.6%−1.0%9.3%
Operating profit growth––––––14.3%−0.3%6.0%29.2%
Net profit growth23.6%28.8%18.5%23.0%––17.7%−4.4%6.6%40.4%
Earnings per share growth––––––––6.6%40.4%
Return on equity–––––––––24.0%
Return on capital employed–––––––––26.4%
Interest cover–––223.0–903.7985.1276.7403.41,385.2
Debt to equity–––––––––0.00
Receivable days–––––––––29
Inventory days–––––––––118
Payable days–––––––––242
Cash conversion cycle, days–––––––––−94
Working capital days–––––––––−49
Asset turnover–––––––––0.79
Assets per rupee of net worth–––––––––1.48
Sales per rupee of plant–––––––––10.35
Plant being built, % of plant in use–––––––––2.7%
No balance sheet is on record for the years to Dec 2009, Dec 2010, Dec 2011, Dec 2012, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2019.

Return on assets, latest year
16.2%
Measure5 years3 years
Revenue growth, yearly rate–3.5%
Profit growth, yearly rate–12.7%
Operating margin, average19.9%21.0%
Net margin, average16.2%17.1%
Interest cover, average790.8688.5

Accounting checks

Standalone, years to December, then March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckDec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Altman Z-scorePublished threshold 1.1–––––––––9.76
Effective tax ratePublished threshold 17.16 per cent34.2233.6334.2532.67–34.3634.9135.0134.8435.01
A threshold marked as ours has no published figure; it is the line we read the check against.